Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc Share Price Today

(NASDAQ: BDRX)

Biodexa Pharmaceuticals Plc share price is $2.99 & ₹260.04 as on 6 Mar 2025, 2.30 'hrs' IST

$2.99

▲

0.19

(6.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Biodexa Pharmaceuticals Plc share price in Dollar and Rupees. Guide to invest in Biodexa Pharmaceuticals Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biodexa Pharmaceuticals Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Biodexa Pharmaceuticals Plc share price movements

  • Today's Low: $2.81
    Today's High: $3.00

    Day's Volatility :6.33%

  • 52 Weeks Low: $2.78
    52 Weeks High: $74.00

    52 Weeks Volatility :96.24%

Biodexa Pharmaceuticals Plc (BDRX) Returns

PeriodBiodexa Pharmaceuticals PlcIndex (Russel 2000)
3 Months
-37.84%
0.0%
6 Months
-69.8%
0.0%
1 Year
-90.73%
0.0%
3 Years
-99.68%
-11.6%

Biodexa Pharmaceuticals Plc (BDRX) Key Statistics

in dollars & INR

Previous Close
$2.8
Open
$2.81
Today's High
$3.0
Today's Low
$2.81
Market Capitalization
$1.9M
Today's Volume
$30.2K
52 Week High
$73.9975
52 Week Low
$2.78
Revenue TTM
$83.0K
EBITDA
$-6.4M
Earnings Per Share (EPS)
$-72.63
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-97.23%

How to invest in Biodexa Pharmaceuticals Plc Stock (BDRX) from India?

It is very easy for Indian residents to invest directly in Biodexa Pharmaceuticals Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biodexa Pharmaceuticals Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biodexa Pharmaceuticals Plc or BDRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biodexa Pharmaceuticals Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biodexa Pharmaceuticals Plc shares which would translate to 0.291 fractional shares of Biodexa Pharmaceuticals Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biodexa Pharmaceuticals Plc, in just a few clicks!

Returns in Biodexa Pharmaceuticals Plc (BDRX) for Indian investors in Rupees

The Biodexa Pharmaceuticals Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biodexa Pharmaceuticals Plc investment value today

Current value as on today

₹14,220

Returns

₹85,780

(-85.78%)

Returns from Biodexa Pharmaceuticals Plc Stock

₹90,729 (-90.73%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Biodexa Pharmaceuticals Plc (BDRX)

538%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Biodexa Pharmaceuticals Plc Stock from India on INDmoney has increased by 538% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Biodexa Pharmaceuticals Plc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Biodexa Pharmaceuticals Plc(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
0
Hold
1
1
3
Sell
0
0
3

Analyst Forecast on Biodexa Pharmaceuticals Plc Stock (BDRX)

What analysts predicted

Upside of 510.08%

Target:

$18.24

Current:

$2.99

Insights on Biodexa Pharmaceuticals Plc Stock (Ticker Symbol: BDRX)

  • Price Movement

    In the last 7 days, BDRX stock has moved down by -13.3%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.65M → -3.30M (in $), with an average decrease of 100.0% per quarter

  • BDRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 157.2%

  • Price to Sales

    ForBDRX every $1 of sales, investors are willing to pay $6.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

BDRX Biodexa Pharmaceuticals Plc Financials in INR & Dollars

FY18Y/Y Change
Revenue
$1.9M
↑ 95.96%
Net Income
$-10.4M
↓ 11.42%
Net Profit Margin
-534.98%
↑ 648.54%
FY19Y/Y Change
Revenue
$882.5K
↓ 65.22%
Net Income
$-12.0M
↓ 11.86%
Net Profit Margin
-1.4K%
↓ 820.81%
FY20Y/Y Change
Revenue
$460.7K
↓ 49.11%
Net Income
$-29.8M
↑ 142.82%
Net Profit Margin
-6.5K%
↓ 5113.31%
FY21Y/Y Change
Revenue
$769.0K
↑ 68.51%
Net Income
$-7.3M
↓ 75.39%
Net Profit Margin
-944.64%
↑ 5524.46%
FY22Y/Y Change
Revenue
$850.9K
↑ 20.93%
Net Income
$-9.3M
↑ 40.22%
Net Profit Margin
-1.1K%
↓ 150.64%
FY23Y/Y Change
Revenue
$482.3K
↓ 45.49%
Net Income
$-9.0M
↓ 7.54%
Net Profit Margin
-1.9K%
↓ 762.73%
Q1 FY23Q/Q Change
Revenue
$180.8K
↓ 35.5%
Net Income
$-2.2M
↓ 61.18%
Net Profit Margin
-1.2K%
↑ 791.86%
Q2 FY23Q/Q Change
Revenue
$376.3K
↑ 100.0%
Net Income
$-4.5M
↑ 100.0%
Net Profit Margin
-1.2K%
↑ 0.0%
Q3 FY23Q/Q Change
Revenue
$41.5K
↓ 86.07%
Net Income
$-1.8M
↓ 50.8%
Net Profit Margin
-4.2K%
↓ 3032.8%
Q4 FY23Q/Q Change
Revenue
$83.0K
↑ 100.0%
Net Income
$-3.5M
↑ 100.0%
Net Profit Margin
-4.2K%
↑ 0.0%
FY18Y/Y Change
Profit
$-7.4M
↑ 1.1%
FY19Y/Y Change
Profit
$-9.4M
↓ 3.4%
FY20Y/Y Change
Profit
$-7.7M
↓ 20.14%
FY21Y/Y Change
Profit
$-5.4M
↓ 28.8%
FY22Y/Y Change
Profit
$-5.4M
↑ 8.24%
FY23Y/Y Change
Profit
$-4.7M
↓ 16.46%
Q1 FY23Q/Q Change
Profit
$-1.2M
↓ 60.42%
Q2 FY23Q/Q Change
Profit
$-2.5M
↑ 100.0%
Q3 FY23Q/Q Change
Profit
$-1.1M
↓ 44.5%
Q4 FY23Q/Q Change
Profit
$-2.2M
↑ 100.0%
Q1 FY24Q/Q Change
Profit
$-1.1M
↓ 49.52%
Q2 FY24Q/Q Change
Profit
$-2.2M
↑ 100.0%
FY19Y/Y Change
Operating Cash Flow
$-8.5M
↓ 51.75%
Investing Cash Flow
$-5.0M
-
Financing Cash Flow
$24.5M
↓ 389.45%
FY20Y/Y Change
Operating Cash Flow
$-12.5M
↑ 43.33%
Investing Cash Flow
$3.5M
↓ 167.61%
Financing Cash Flow
$4.1M
↓ 83.54%
FY21Y/Y Change
Operating Cash Flow
$-8.0M
↓ 35.4%
Investing Cash Flow
$-369.9K
↓ 110.8%
Financing Cash Flow
$11.7M
↑ 185.51%
Q1 FY23Q/Q Change
Operating Cash Flow
$-2.4M
↓ 44.7%
Investing Cash Flow
$12.1K
↑ 0.0%
Financing Cash Flow
$3.8M
↑ 2400.8%
Q2 FY23Q/Q Change
Operating Cash Flow
$-4.9M
↑ 100.0%
Investing Cash Flow
$12.6K
↑ 0.0%
Financing Cash Flow
$7.9M
↑ 100.0%

Biodexa Pharmaceuticals Plc Technicals Summary

Sell

Neutral

Buy

Biodexa Pharmaceuticals Plc is currently in a neutral trading position according to technical analysis indicators.

Biodexa Pharmaceuticals Plc (BDRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biodexa Pharmaceuticals Plc logo
Biodexa Pharmaceuticals Plc
-31.26%
-69.8%
-90.73%
-99.68%
-99.68%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
Beone Medicines Ltd
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biodexa Pharmaceuticals Plc logo
Biodexa Pharmaceuticals Plc
NA
NA
NA
-0.05
-0.97
-0.38
NA
24.07
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biodexa Pharmaceuticals Plc logo
Biodexa Pharmaceuticals Plc
Buy
$1.9M
-99.68%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
126.66%
NA
-12.37%

About Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTD217, a program centered around a water-soluble drug formulation that can be easily infused or injected simultaneously, or sequentially, directly into the cancer microenvironment, currently under preclinical studies for the treatment of leptomeningeal disease. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Organization
Biodexa Pharmaceuticals Plc
Employees
21
CEO
Mr. Stephen Anthony Stamp
Industry
Miscellaneous

Management People of Biodexa Pharmaceuticals Plc

NameTitle
Mr. Stephen Anthony Stamp
CEO, CFO, Company Secretary & Director
Dr. Daniel Palmer MBA, Ph.D.
Vice President of Technology
Ms. Nicola Tuckwell
VP & Head of Clinical Operations
Mr. Steve Ellul
Chief Business Officer
Dr. Gary A. Shangold CPI, FACOG, M.D.
Chief Medical Officer
Ms. Fiona Sharp
Group Financial Controller

Important FAQs about investing in BDRX Stock from India :

What is Biodexa Pharmaceuticals Plc share price today?

Biodexa Pharmaceuticals Plc share price today stands at $2.99, Open: $2.81 ; Previous Close: $2.80 ; High: $3.00 ; Low: $2.81 ; 52 Week High: $74.00 ; 52 Week Low: $2.78.

The stock opens at $2.81, after a previous close of $2.80. The stock reached a daily high of $3.00 and a low of $2.81, with a 52-week high of $74.00 and a 52-week low of $2.78.

Can Indians buy Biodexa Pharmaceuticals Plc shares?

Yes, Indians can invest in the Biodexa Pharmaceuticals Plc (BDRX) from India.

With INDmoney, you can buy Biodexa Pharmaceuticals Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Biodexa Pharmaceuticals Plc at zero transaction cost.

How can I buy Biodexa Pharmaceuticals Plc shares from India?

It is very easy to buy Biodexa Pharmaceuticals Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biodexa Pharmaceuticals Plc (BDRX) be purchased?

Yes, you can buy fractional shares of Biodexa Pharmaceuticals Plc with INDmoney app.

What are the documents required to start investing in Biodexa Pharmaceuticals Plc stocks?

To start investing in Biodexa Pharmaceuticals Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Biodexa Pharmaceuticals Plc Stock (BDRX)?

Today’s highest price of Biodexa Pharmaceuticals Plc (BDRX) is $3.00.

Today’s lowest price of Biodexa Pharmaceuticals Plc (BDRX) is $2.81.

What is today's market capitalisation of Biodexa Pharmaceuticals Plc?

Today's market capitalisation of Biodexa Pharmaceuticals Plc BDRX is 1.9M

What is the 52 Week High and Low Range of Biodexa Pharmaceuticals Plc Stock (BDRX)?

  • 52 Week High

    $74.00

  • 52 Week Low

    $2.78

What are the historical returns of Biodexa Pharmaceuticals Plc (BDRX)?

  • 1 Month Returns

    -31.26%

  • 3 Months Returns

    -69.8%

  • 1 Year Returns

    -90.73%

  • 5 Years Returns

    -99.68%

Who is the Chief Executive Officer (CEO) of Biodexa Pharmaceuticals Plc ?

Mr. Stephen Anthony Stamp is the current Chief Executive Officer (CEO) of Biodexa Pharmaceuticals Plc.